The FDA has accepted for Priority Review the supplemental BLA for Rituxan for use in combination with glucocorticoids for the treatment of granulomatosis with polyangiitis and microscopic polyangiitis in children ≥2 years old.
Children with chronic illness have lower general health, but their life satisfaction is comparable to that of their peers without chronic illness.
Study showed that pamidronate might contribute to clinical improvement and improvement of radiologic outcome in chronic nonbacterial osteomyelitis, however, relapses were frequent.
The American College of Rheumatology and the Arthritis Foundation have released updated recommendations for the screening, monitoring, and treatment of juvenile idiopathic arthritis with associated uveitis.
The American College of Rheumatology and Arthritis Foundation have released updated guidelines for management of non-systemic polyarthritis, sacroiliitis, and enthesitis in patients with juvenile idiopathic arthritis.
Patients with JIA who received tocilizumab therapy experienced transient neutropenia that was not associated with an increased number of infections.
Although there was high agreement and similar classification of change among the questionnaires, these may not be completely interchangeable.
Researchers examined the ABCG2 gene in a hyperuricemia and gout cohort, focusing on patients with pediatric-onset disease.
Patients with juvenile mixed connective tissue disease had impaired left and right ventricular function compared with matched controls after a median of 15 years disease duration.
Data show that more than half of patients with juvenile idiopathic arthritis were no longer on methotrexate therapy.
